Oslo, 10 September 2026 - Observe Medical ASA (the "Company" or "Observe Medical") is pleased to announce our entry into the Philippine market after having received the first significant order of UnoMeter Safeti Plus and UnoMeter Safeti Max.
The Philippines is one of Southeast Asia's fastest-growing healthcare markets, with healthcare expenditure increasing by approximately 75% in real terms between 2015 and 2021, the strongest growth among ASEAN countries. Combined with a large population, rising healthcare investment and significant unmet medical needs, the market represents an attractive long-term opportunity for innovative medtech solutions.
Jørgen Mann, CEO of Observe Medical, commented: "With the establishment of a partnership with a local distributor with high ambitions and competencies within our segment, together with an attractive market coverage, we have now started the journey of growth in this region where we are already well represented in Thailand and Vietnam. This first order of our two most innovative products is significant as we see that the market offers an attractive platform for continued growth in the region."
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.